Yifan Kong

4PUBLICATIONS
12CO-AUTHORS
Molecular targetsSolid tumoursSeparation technologiesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 18, 2025
The kinase PLK1 promotes Hedgehog signaling-dependent resistance to the antiandrogen enzalutamide in metastatic prostate cancer.

Qiongsi Zhang, Jia Peng, Yanquan Zhang

|Oct 04, 2022
The kinase PLK1 promotes the development of Kras/Tp53-mutant lung adenocarcinoma through transcriptional activation of the receptor RET.

Yifan Kong, Derek B Allison, Qiongsi Zhang

|May 16, 2019
Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer.

Yunfeng Bai, Zhuangzhuang Zhang, Lijun Cheng

|Aug 10, 2018
Inhibition of cholesterol biosynthesis overcomes enzalutamide resistance in castration-resistant prostate cancer (CRPC).

Yifan Kong, Lijun Cheng, Fengyi Mao

Pageof 1

Frequent Collaborators

2 joint publications

Yanquan Zhang

2 joint publications

Chi Wang

1 joint publications

Derek B Allison

1 joint publications

Christine F Brainson